This is a federal contract award to the Massachusetts Institute of Technology (MIT), a private research university, by the U.S. Department of Defense's Research, Development and Engineering Command (RDECOM). The $3,789,097.93 cost-no-fee delivery order contract is for management, administration, and outreach services and has a period of performance through March 31, 2028. This award is not associated with a set-aside designation. MIT frequently partners with the federal government on research...
This federal contract award, valued at $6,038,686.00, was issued by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) to generate a Broad Agency Announcement (BAA) addressing the ongoing growth in continuous manufacturing within cell lines. The requirement is being funded through the President's initiative to focus on advanced manufacturing. This is a definitive, firm-fixed-price contract with a period of performance through September 29, 2027. No...
This is a firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs to the Massachusetts Institute of Technology (MIT) for $85,581.93. The contract is for the provision of medical equipment and does not have a set-aside designation. This contract is part of MIT's broader portfolio of federal contracts and grants, which often involve cutting-edge research and development in areas like advanced materials, space...
This is a $1,000,000.00 Other Transaction Agreement (OTA) awarded by the Defense Advanced Research Projects Agency (DARPA) to the Massachusetts Institute of Technology (MIT), a private research university. The contract is for the development of tunable visible light materials, which aligns with DARPA's focus on advanced materials research and cutting-edge technology. MIT, as a world leader in science and technology, has a long history of providing research, engineering, and technical services to...
This federal contract award, identified as W911NF13D0001|0008, was issued by the Defense Advanced Research Projects Agency (DARPA) to the Massachusetts Institute of Technology (MIT), a private research university, for an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract titled "ISN UARC (BASIC RESEARCH)." The contract, which has no set-aside designation, has a ceiling value of $13,429,820.66 and a performance period that extends through August 23, 2024. Under this ID/IQ...
This is a delivery order contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to the Massachusetts Institute of Technology (MIT) on February 8, 2013. The contract, titled "ISN UARC (BASIC RESEARCH)", has a potential value of $5,115,233.21 and is set to be completed by December 31, 2022. The contract is a cost-sharing arrangement and is not set aside for any specific business designation. MIT is a private research university that...
This is a $5,000,001.00 definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) for "APPLICATION OF SMART DATA ANALYTICS FOR BIOMANUFACTURING." The contract has no set-aside designation and is a cost-type contract without fee. The contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which solicits research and development proposals across various regulatory science areas to...
This is a $7,399,980.00 federal contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Haverford College, a private non-profit educational institution, for the "Synergistic Discovery & Design (SD2) Phase 1 - Base" research effort. The contract is for combined research in Technical Areas 2 and 3 to develop automated, high-throughput robotic platforms for organohalide hybrid perovskite discovery and models for organohalide perovskite formation and stability. The...
This is a $4,999,325.00 federal contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) to conduct research on controlled protein capture via continuous crystallization and precipitation for monoclonal antibody manufacturing. The contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science and does not have a set-aside designation. The contract involves research and development activities to advance...
The U.S. government's Research, Development and Engineering Command (RDECOM) has awarded a $360,500.00 cost-no-fee delivery order contract to the Massachusetts Institute of Technology (MIT) to execute a new research task proposal. This task order falls under a larger RDECOM indefinite-delivery/indefinite-quantity (IDIQ) other transaction authority contract with MIT, which aims to develop resonantly-bonded visible-band tunable materials for potential defense applications like active camouflage,...